Загрузка...
The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany
BACKGROUND: Many countries worldwide reported side effects of the coronavirus disease 2019 (COVID-19) pandemic that have influenced the care of patients with other diseases in both acute and elective settings. Patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) r...
Сохранить в:
| Опубликовано в: : | Ther Adv Neurol Disord |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8267031/ https://ncbi.nlm.nih.gov/pubmed/34285719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17562864211030656 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|